JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KRAYER, O.
Right arrow Articles by PLACHTE, F. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by KRAYER, O.
Right arrow Articles by PLACHTE, F. L.
Journal of Pharmacology And Experimental Therapeutics, Vol. 80, Issue 1, 8-30, 1944
Copyright © 1944 by American Society for Pharmacology and Experimental Therapeutics


STUDIES ON PHYSOSTIGMINE AND RELATED SUBSTANCES I. QUANTITATIVE RELATION BETWEEN DOSAGE OF PHYSOSTIGMINE AND INHIBITION OF CHOLINESTERASE ACTIVITY IN THE BLOOD SERUM OF DOGS

OTTO KRAYER 1, AVRAM GOLDSTEIN 1, and FRANK L. PLACHTE 1

1 From the Department of Pharmacology, Harvard Medical School, Boston

1. The time course of the inhibition of serum cholinesterase activity has been followed in detail after single intravenous doses of physostigmine in dogs.

2. With continuous intravenous infusions of physostigmine in dogs a steady level of inhibited serum cholinesterase activity is reached within one hour and may be maintained for as long as the infusion lasts.

3. The percentage level of serum cholinesterase inhibition attained by a constant rate of infusion is reproducible and allows quantitative definition of "eserinization" when employed for physiological experiments involving cholinergic mechanisms.

4. The kidneys are proved to play a minor rôle in the disposal of physostigmine.

5. The recovery of serum cholinesterase activity in vivo after continuous infusion and after large single doses appears to follow a mechanism similar to the recovery of the inhibited enzyme activity in vitro.

6. The validity of determinations of inhibited enzymes is discussed from the standpoint of the various methods which may be employed in such determinations. Combination of inhibitor with enzyme, destruction of inhibitor, dilution, displacement of inhibitor by substrate, and time are shown to be among the factors by which methods differ, and which require proper correction. A basis is provided for understanding and evaluating the unfamiliar corrections applied to the data presented in this paper.

Submitted on August 4, 1943







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1944 by the American Society for Pharmacology and Experimental Therapeutics.